Your Input: | |||||
gnaq | Guanine nucleotide-binding protein (G protein), q polypeptide. (359 aa) | ||||
pdgfrb | Platelet-derived growth factor receptor, beta polypeptide; Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily. (1072 aa) | ||||
fgfr4 | Fibroblast growth factor receptor 4; Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down- regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation o [...] (923 aa) | ||||
camta1 | Calmodulin-binding transcription activator 1. (109 aa) | ||||
notch1a | Neurogenic locus notch homolog protein 1; Functions as a receptor for membrane-bound ligands Jagged-1 (JAG1), Jagged-2 (JAG2) and Delta-1 (DLL1) to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs. Involved in angiogenesis; negatively regulates endothelial cell proliferation and migration and angiogenic sprouting. Involved in the [...] (2438 aa) | ||||
tfe3a | Transcription factor-binding to IGHM enhancer 3a. (539 aa) | ||||
kdrl | Vascular endothelial growth factor receptor kdr-like; Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. Combinations of multiple VEGF receptors are required for development of different blood vessel types in the embryo. Involved in angiogenesis, specifically in VEGF-induced sprouting of new blood vessels. Particularly involved in artery formation. Does not appear to be required for hematopoiesis. (1301 aa) | ||||
flt4 | Vascular endothelial growth factor receptor 3; Tyrosine-protein kinase that acts as a cell-surface receptor for vegf or vegfc. Combinations of multiple VEGF receptors are required for development of different blood vessel types in the embryo. Involved in angiogenesis, specifically in VEGF-induced sprouting of new blood vessels, but not required for proper vasculogenesis or hematopoiesis. (1368 aa) | ||||
hif1al | Hypoxia-inducible factor 1 subunit alpha,-like. (626 aa) | ||||
tfe3b | Transcription factor-binding to IGHM enhancer 3b. (451 aa) | ||||
gna14 | Guanine nucleotide-binding protein (G protein), alpha 14. (354 aa) | ||||
gna11a | Guanine nucleotide-binding protein (G protein), alpha 11a (Gq class). (359 aa) | ||||
fosb | FBJ murine osteosarcoma viral oncogene homolog B. (411 aa) | ||||
or111-7 | Odorant receptor, family D, subfamily 111, member 7. (325 aa) | ||||
mtor | Serine/threonine-protein kinase TOR; Belongs to the PI3/PI4-kinase family. (2563 aa) | ||||
yap1 | Transcriptional coactivator YAP1; Transcriptional regulator which can act both as a coactivator and a corepressor and is the critical downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (By similarity). Required for expansion of the neural plate and neural plate border zone progenitor pools. Acts as a direct regulator of pax3 expression via interaction with tead1. Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin netwo [...] (442 aa) | ||||
wwtr1 | WW domain-containing transcription regulator 1. (391 aa) | ||||
serpine1 | Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; Belongs to the serpin family. (392 aa) | ||||
nras | GTPase NRas; Ras proteins bind GDP/GTP and possess intrinsic GTPase activity; Belongs to the small GTPase superfamily. Ras family. (188 aa) | ||||
kdr | Vascular endothelial growth factor receptor 2; Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. Combinations of multiple VEGF receptors are required for development of different blood vessel types in the embryo. Involved in angiogenesis, specifically in VEGF-induced sprouting of new blood vessels. Particularly involved in artery formation. Does not appear to be required for hematopoiesis. (1357 aa) | ||||
braf | B-Raf proto-oncogene, serine/threonine kinase. (817 aa) | ||||
camta1b | Calmodulin-binding transcription activator 1b. (1626 aa) | ||||
hif1aa | Hypoxia-inducible factor 1 subunit alpha a. (717 aa) | ||||
idh2 | Isocitrate dehydrogenase (NADP(+)) 2. (225 aa) | ||||
hif1ab | Hypoxia-inducible factor 1 subunit alpha b. (777 aa) |